Abstract

BackgroundTo strengthen medicines management capacity, including supply chain management, at public sector health facilities in Uganda, the Ministry of Health introduced a multipronged supervision, performance assessment, and recognition strategy (SPARS). The aim of this study was to assess the impact of SPARS on improving supply chain management. A series of four papers on SPARS described the SPARS concept, its impact on overall and domain practices and appropriate medicines use, and now in the fourth paper describing the effect on supply chain management.MethodsDistrict-based health workers trained as supervisors build facility-level capacity in medicines management using an indicator-based performance assessment followed by targeted supervisory visits. From 2010 to 2013, 1222 SPARS visits were implemented, and the SPARS performance indicator scores determined. This article assesses impact on 13 indicators in three of the five SPARS domains—stock management, storage management, and ordering and reporting quality—using a pre–post design. We also explored factors that may have influenced these outcomes.ResultsBetween the first and last visit within one year of SPARS implementation, we found an average improvement of 16 percentage points (p < 0.001) in supply chain management measures across all levels of care. The improvement in scores for stock management, storage management, and ordering and reporting was 22 (ns), 16 (p < 0.001), and 11 (p = 0.032) percentage points, respectively. The study identified the key predictors of positive change as a low initial indicator score, frequent supervisory visits, and engagement of the district health officer.ConclusionsThe multipronged SPARS approach was effective in building supply chain management capacity in lower-level health care facilities with statistically significant improvements in supply chain management overall and in almost all stock and storage- management and ordering and reporting measures after one year of implementation. We recommend broad dissemination of the SPARS approach as an effective strategy to strengthen supply chain management in low-income countries.Trial registration: The study did not involve or use human participants or identifiable personal data, human tissue, or animals and thus did not require ethical approval or a waiver. It is a study implemented in collaboration with the Ministry of Health and does not require trial registration.

Highlights

  • To strengthen medicines management capacity, including supply chain management, at pub‐ lic sector health facilities in Uganda, the Ministry of Health introduced a multipronged supervision, performance assessment, and recognition strategy (SPARS)

  • Though Uganda is committed to ensuring universal access to essential medicines, the health system and the pharmaceutical supply chain have for decades faced many documented constraints, including persistently low availability of Essential medicines and health supplies (EMHS), weak stock and storage management, high rates of product expiry, and an inability to correctly quantify needs or make timely orders [1, 2, 8]

  • To examine the impact of SPARS supervision on specific supply chain management (SCM) practices included in the SPARS assessment tool, we examined changes from the initial visit to the last assessment visit that occurred during the first 12 months of supervision in 1222 government and private not-for-profit (PNFP) health facilities at all levels of care in 45 districts

Read more

Summary

Introduction

To strengthen medicines management capacity, including supply chain management, at pub‐ lic sector health facilities in Uganda, the Ministry of Health introduced a multipronged supervision, performance assessment, and recognition strategy (SPARS). Essential medicines and health supplies (EMHS) of good quality should be available and accessible at all levels of care to achieve optimal health outcomes [1,2,3]. Though Uganda is committed to ensuring universal access to essential medicines, the health system and the pharmaceutical supply chain have for decades faced many documented constraints, including persistently low availability of EMHS, weak stock and storage management, high rates of product expiry, and an inability to correctly quantify needs or make timely orders [1, 2, 8]. Implemented supply chain management (SCM) can result in significant financial losses, lack of EMHS availability, high rates of expiry, acceleration of drug resistance, and poor health outcomes [11]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call